Skip to main content

Table 1 The Demographic, clinical presentation, laboratory and neuroradiological data of the participants

From: Could vertigo be a post-COVID-19 sequela or presenting symptom?

 

Post-Covid-19 patients (n = 7)

Close contacts (n = 37)

Demographic data

  Age (years) Mean ± SD

49.8 ± 13.9

52.2 ± 13

  Sex (Male: Female)

1 (14.3%):6 (85.7%)

21(56.8%): 16(43.2%)

Clinical presentation

  Positional vertigo

1 (14.3%)

16 (43.2%)

  Balance difficulties

6 (85.7%)

21 (56.8%)

Laboratory data

  

 Serum ferritin

  

  Normal

7 (100%)

33 (89.2%)

  Elevated

–

4 (10.8%)

 CBC

  

  Normal

7 (100%)

27 (73%)

  Leucopenia

–

1 (2.7%)

  Lymphopenia

–

6 (16.2%)

  Lymphopenia and Leucopenia

–

1 (2.7%)

  Lymphopenia and Leukocytosis

–

2 (5.4%)

 CRP

  

  Negative

3 (42.9%)

23 (62.2%)

  Positive

4 (57.1%)

14 (37.8%)

 Liver enzymes

  

  Normal

7 (100%)

33 (89.2%)

  Elevated

–

4 (10.8%)

 CT chest at vertigo presentation

  

  Normal

6 (85.7%)

36 (97.3%)

  Fibrotic

1 (14.3%)

0 (0%)

  GGO

0 (0%)

1 (2.7%)

  1. GGO ground glass opacification